Clinical Trials Directory

Trials / Unknown

UnknownNCT01450150

Transcranial Direct Current Stimulation as an Augmenting Intervention for Major Depression

Transcranial Direct Current Stimulation (tDCS) as an Augmenting Intervention for Treatment-Resistant Major Depression: A Randomized, Double-Blind and Sham-Controlled Trial

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Douglas Mental Health University Institute · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Transcranial direct current stimulation (tDCS) is a noninvasive method to activate or de-activate neurons in superficial regions of the brain through the induction of weak electric currents in the brain tissue delivered by two scalp electrodes. Initial studies have shown tDCS to be effective for treating major depressive disorder (MDD), although there are negative trials in the specialized literature. One reason for these discrepant results might be that the duration of tDCS treatment in clinical trials to date (up to 2 weeks) is still insufficient to produce consistent clinical improvements. Thus, we intend to assess, in a sample of outpatients with MDD, whether a 3-week adjunctive course of active tDCS over the left dorsolateral prefrontal cortex is associated with a significant clinical improvement when compared to sham tDCS. The investigators hypothesize that subjects receiving active tDCS will present with significantly higher response and remission rates at weeks 3.

Conditions

Interventions

TypeNameDescription
DEVICETranscranial Direct Current Stimulation20-minute daily sessions of 2 mA tDCS for 15 days (Monday to Friday on three consecutive weeks)
DEVICETranscranial Direct Current StimulationThe tDCS stimulator will be turned on for 30 seconds only, after which it will be gradually decreased and then turned off for the remainder of the 20-minute daily sessions for 15 days (Monday to Friday on three consecutive weeks).

Timeline

Start date
2016-01-01
Primary completion
2018-10-01
Completion
2018-10-01
First posted
2011-10-12
Last updated
2016-01-20

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01450150. Inclusion in this directory is not an endorsement.